bioRxiv

From Wikipedia, the free encyclopedia
Jump to: navigation, search
bioRxiv
BioRxiv logo.png
Type of site
Science
Available in English
Owner Cold Spring Harbor Laboratory
Slogan(s) The Preprint Server for Biology
Website biorxiv.org
Alexa rank Increase 31,553 (as of July 2017)[1]
Commercial No
Launched November 2013; 3 years ago (2013-11)
Current status Online

bioRxiv is a preprint repository for the biological sciences launched in November 2013.[2] It is hosted by the Cold Spring Harbor Laboratory (CSHL),[3] as preprints, papers hosted on bioRxiv are not peer-reviewed, but undergo basic screening and checked against plagiarism. Readers may offer comments on the preprint, it was inspired by and intends to complement the arXiv repository, which mostly focuses on physics and connected disciplines, launched in 1991 by Paul Ginsparg (who also serves on the bioRxiv advisory board). It received support from both the CSHL and the Lourie Foundation.[4] Additional funding from the Chan Zuckerberg Initiative was confirmed in April 2017.[5][6]

Prior to the establishment of bioRxiv, biological scientists were divided on the issue of having a dedicated preprint repository.[2] Many had concerns of having their research scooped by competitors and losing their claim to discovery. However, several geneticists had submitted papers to the "quantitative biology" section of the arXiv repository (launched in 2003) and no longer had those concerns, as they could point to preprints to support their claims of discovery.[2][7]

As a result of bioRxiv's popularity, several (but not all) biology journals have updated their policies on preprints.[4][8] clarifying they do not consider preprints to be a 'prior publication' for purpose of the Ingelfinger rule. Over 20,000 tweets were made about bioRxiv-hosted preprints[4] in 2015; in July 2017, the number of monthly submissions exceeded 1,000.[9]

Submission rate[edit]

Jocelyn Kaiser of Science said that in their first year, the repository had "attracted a modest but growing stream of papers", having hosted 824 preprints,[8] as of February 2016, the submission rate to bioRxiv had steadily increased from ~60 to ~200 per month, with a total of 3100 papers received.[4] As of April 21, 2017, >10,000 papers have been accepted in total.[10] In 2017, the number of monthly submissions was more than 810 in March [11] and more than 1000 in July.[9]


Fields[edit]

bioRxiv accepts preprints in the following disciplines

bioRxiv to Journals[edit]

The bioRxiv to Journals (B2J) initiative allows authors to submit their manuscript directly to a journal's submission system through bioRxiv. Journals currently participating in B2J are:

See also[edit]

References[edit]

  1. ^ "biorxiv.org Site Overview". Alexa Internet. Retrieved 2017-07-20. 
  2. ^ a b c Callaway, Ewen (12 November 2013). "Preprints come to life". Nature. 503 (7475): 180. doi:10.1038/503180aFreely accessible. 
  3. ^ "About bioRxiv". bioRxiv. Cold Spring Harbor Laboratory. Retrieved 2016-09-07. 
  4. ^ a b c d Inglis, John R.; Sever, Richard (12 February 2016). "bioRxiv: a progress report". ASAPbio. Retrieved 2016-09-11. 
  5. ^ Callaway, Ewen. "BioRxiv preprint server gets cash boost from Chan Zuckerberg Initiative". Nature. doi:10.1038/nature.2017.21894. 
  6. ^ "BioRxiv preprint server gets funding from Chan Zuckerberg Initiative". Science | AAAS. 2017-04-26. Retrieved 2017-04-28. 
  7. ^ Callaway, Ewen (31 July 2012). "Geneticists eye the potential of arXiv". Nature. 488 (7409): 19. PMID 22859182. doi:10.1038/488019aFreely accessible. 
  8. ^ a b Kaiser, Jocelyn (11 November 2014). "BioRxiv at 1 year: A promising start". Science. Retrieved 2016-09-07. 
  9. ^ a b Inglis, John (2017-06-30). "A life sci #preprint milestone: @biorxivpreprint’s first >1000 ms month. Thanks to authors, affiliates, and staff for making it happen". @JohnRInglis. Retrieved 2017-07-02. 
  10. ^ "Search Results | bioRxiv". biorxiv.org. Retrieved 2017-02-16. 
  11. ^ "John Inglis on Twitter". Twitter. Retrieved 2017-03-01. 

Further reading[edit]

External links[edit]